Our Team

Donna Tuths

President & CEO

Donna Tuths has more than 25 years’ experience in healthcare marketing as a technology and marketing executive. Most recently, she held both the Chief Innovation Officer and Chief Marketing Officer roles establishing the AI product development team and sales and marketing capabilities at Sutherland, a key player in AI-driven healthcare customer support services. Ms. Tuths was a Managing Director at Accenture Life Sciences and helped found Accenture Interactive establishing Accenture as a global leader in digital transformation. She is also the former CEO of Ogilvy Healthworld where she launched drugs to market for leading biopharma companies including Pfizer, AstraZeneca, Novartis, Lilly, Merck, and Bristol Myers Squibb. Ms. Tuths was recognized for her leadership in medical marketing by Med Ad News who named her Industry Person of the Year. She joined Perthera’s Board of Directors in January 2023 as Board Chair. Donna is a life member of the Council on Foreign Relations and an Advisory Board member to the Yale Center for Consumer Insights. She is a faculty member covering Digital Marketing in the executive education program at the Yale School of Management.  She holds an AB from Barnard College, MA from the Paul Nitze School of Advanced International Studies, and MBA from the Yale School of Management.

Aurelija Urbonaviciute

Director of Software Engineering

16+ years of experience in product development and tech leadership roles. Ex Startup CEO.

Edik Blais, PhD

VP of Research

Biomedical Engineer with expertise in cancer biology, biostatistics and data science.

Dzung Thach

Director of Computational Biology

Dzung Thach is a Computational Biologist with extensive experience in Bioinformatics. He earned his PhD in molecular microbiology and immunology from the Johns Hopkins School of Public Health in Baltimore, MD, and BS degree in biology from Virginia Tech. 

Emanuel “Chip” Petricoin, PhD

Chief Science Officer

George Mason University Professor, School Of Systems Biology Co-Director, Center For Applied Proteomics And Molecular Medicine.

Michael Pishvaian, MD, PhD

Chief Medical Advisor

Oncologist And Director Of Clinical Research Programs for Johns Hopkins Kimmel Cancer Center.

Derek Raghavan, MD, PhD, FACP, FRACP, FASCO

Chief Medical Officer

Chief Medical Officer, Perthera; Attending Medical Oncologist at Veterans Administration Health Care Center; Associate Editor, JCO Journal of Oncology Practice.

Patricia De Arbeloa, MD, MSc

VP of Medical Affairs

Experienced Medical Director with a demonstrated history of working in the hospital and health care industry.

Senait Fesseha

VP of Finance

20+ years of experience in financial analytics and business operations with a focus on operational efficiency and quality.

Donna Tuths

Board Chairperson

Donna Tuths has more than 25 years’ experience in healthcare marketing as a technology and marketing executive. Most recently, she held both the Chief Innovation Officer and Chief Marketing Officer roles establishing the AI product development team and sales and marketing capabilities at Sutherland, a key player in AI-driven healthcare customer support services. Ms. Tuths was a Managing Director at Accenture Life Sciences and helped found Accenture Interactive establishing Accenture as a global leader in digital transformation. She is also the former CEO of Ogilvy Healthworld where she launched drugs to market for leading biopharma companies including Pfizer, AstraZeneca, Novartis, Lilly, Merck, and Bristol Myers Squibb. Ms. Tuths was recognized for her leadership in medical marketing by Med Ad News who named her Industry Person of the Year. She joined Perthera’s Board of Directors in January 2023 as Board Chair. Donna is a life member of the Council on Foreign Relations and an Advisory Board member to the Yale Center for Consumer Insights. She is a faculty member covering Digital Marketing in the executive education program at the Yale School of Management.  She holds an AB from Barnard College, MA from the Paul Nitze School of Advanced International Studies, and MBA from the Yale School of Management.

Andrew Black

Board Member

Andrew is a serial entrepreneur and investor working with the best minds in government and industry, helping to build data-driven solutions for the complex international challenges of our era. Andrew is an accomplished sales leader in federal and large multinational corporations, and his technology expertise is in AI/ML, DevSecOps, and Quantum Information Systems.

Einaras Von Gravrock

Board Member

Serial entrepreneur and technology investor. Einaras founded CUJO AI to secure everything that connects to the internet, becoming by far the biggest IoT security company protecting more than 1.5 billion devices and 40 million homes. Notable Achievements: Founded, led CUJO AI to become the largest IoT security firm in the world. Named a “Technology Pioneer” by the World Economic Forum and invited to attend Davos in 2019. Named a “Global Innovator” by The World Economic Forum in 2020.

Margot P. Schoenborn

Board Observer

Margot Schoenborn is Vice President, Head of Oncology Strategy & Business Management for Laboratory Corporation of America Holdings (“Labcorp”) (NYSE:LH), and S&P 500 company headquartered in Burlington, North Carolina. Margot is responsible for driving the oncology strategy across drug development and diagnostic segments and manages the precision medicine drug development sales and client services teams. Margot joined Labcorp in July 2021 through its acquisition of OmniSeq, Inc., where she served as Chief Executive Officer and Board Director from May 2019 through July 2021. Margot was part of the Roswell Park Comprehensive Cancer Center team, where she served as Deputy General Counsel, that spun out OmniSeq in 2015, and held roles as OmniSeq’s CAO & General Counsel from 2015 through her appointment as CEO of OmniSeq in 2019 after OmniSeq secured its Series B funding. Margot continued as VP, Head of OmniSeq through December 2022 when OmniSeq was fully integrated into Labcorp. Margot is a seasoned business executive and attorney with experience in corporate development, transactions, capital market activities, corporate finance, and leadership of multi-functional teams over 20+ year career in healthcare, state and federal healthcare law enforcement, and commercial litigation. Margot received her JD, cum laude, from University at Buffalo School of Law, where she served as Editor in Chief of the Human Rights Law Review. Margot received her bachelor degree cum laude from Nazareth College. Margot lives in Buffalo, New York with her husband, Jeff, and their two boys.

Nan Hayworth, MD

Board Member

Dr. Nan Hayworth is a Business Development Advisor with Pilot Growth Equity, and a Consulting Medical Director in healthcare communications and special projects for The Kinetix Group. She graduated from Princeton University with an A.B. in biology. She then studied at Cornell University Medical College, after which she trained in ophthalmology at Mount Sinai Hospital, New York. Nan practiced ophthalmology for 16 years in Mount Kisco, New York, growing her own solo practice for several years before being a partner in the Mount Kisco Medical Group (now CareMount Medical). She has been honored by being made an Assistant Clinical Professor at Mount Sinai Hospital as well as by being named to many “Best Doctors” lists. She then went on to serve as a vice president and medical director at Cline Davis & Mann, a healthcare communications agency in New York, and a division of Omnicom, where her client was Genentech. Nan is the only woman physician in history to be elected a voting Member of the House of Representatives, serving the 19th District of New York in the 112th Congress.

William Lee

Board Member

William Lee is a founder and managing partner of Pilot Growth Equity and is based in San Francisco. Will has been creating software for over 30 years and investing in technology companies for over 20 Years. He is a visionary technology entrepreneur, operator, systems architect, and investor. Will is the creator of NavPod, Pilot Growth’s artificial intelligence based automated deal sourcing and workflow engine. Will currently serves on the boards of 4 technologies, Tailwind, Velocidi, and Webgility. Will’s other active investments in the funds include Bizzabo, CB Insights, And Metabiota. Will’s previous investments include Zenedge (acquired by Oracle), where he served on the board, FirstBest Systems (acquired by Guidewire), Counsyl (acquired by Myriad Genetics), CUJO AI, and PMC.

Yehuda Neuberger

Board Member

Yehuda Neuberger is the President of Brownstone Recovery Group. Neuberger is an active private equity investor with investments in a range of companies in various sectors including financial services, back office processing, and business software. Neuberger serves on the boards of directors for many companies and not-for-profit institutions, including publicly-held Maiden Holdings. From 2001 to 2008, Neuberger was Executive Vice President of American Stock Transfer & Trust Company, and continues to serve on its board and on the board of its international parent, Armor Holdco. Prior to that, Neuberger was an attorney with the firm of Weil, Gotshal & Manges, LLP. Neuberger is a graduate of Johns Hopkins University and Harvard Law School.

James “Sandy” Winnefeld, Jr.

Scientific Advisor

John L. Marshall, MD

Scientific Advisor

Jonathan Brody, Ph. D.

Scientific Advisor

THIS IS AI-POWERED PRECISION ONCOLOGY

Contact Us